NCT07400042Recruiting
Peripheral Venous Pressure (PVP) Trial
Reducing the Length of Stay and Incidence of Rehospitalization in Heart Failure Patients by Measuring Peripheral Venous Pressure; a Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
The purpose of the study is to determine if there is a reduction in the length of stay and rates of rehospitalization for patients diagnosed with congestive heart failure when physicians are provided daily measurements of peripheral venous pressure versus no daily measurements of peripheral venous pressure.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- First submitted
- 21 Jan 2026
- Start date
- 5 Oct 2026
- Primary completion date
- Oct 2031
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Heart failure
- NCT number
- NCT07400042
What you commit to
- Study type: Interventional
- Planned participants: 600
- From 5 Oct 2026 to the primary completion date, Oct 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have experienced a major cardiovascular event (myocardial infarction, stroke, etc.) ≤2 months prior to the admission date
- Patients who have received an implanted cardiac resynchronization device (pacemaker or ICD) ≤3 months prior to admission date
Other illness
- Patients with current or past vein thrombosis in the arm used to measure the pressure or with history of recurrent (\>1) pulmonary embolism
- Patients with a clinical condition that the investigator believes may not allow the patient to complete the study, at the discretion of the investigator. Examples of conditions that may apply include severe stenotic valvular disease, isolated right ventricle failure, precapillary pulmonary hypertension, hypertrophic obstructive cardiomyopathy, implanted left ventricular assist device, history of heart transplantation, clinical diagnosis of cardiogenic shock, any left-to-right shunt
- Patients with congenital heart disease or mechanical right heart valve(s)
- Planned heart surgery and/or coronary intervention during hospitalization
- Patients expected to receive heart transplant within 6 months of admission
Other
- Patients who do not already have a peripheral IV line inserted
- Patients whose IV line cannot be transduced
- Patients with active thrombophlebitis in the arm
- Patients enrolled in other cardiovascular research studies.
- IV cannula smaller than 22G
- Patients who are pregnant and/or lactating
- Patients who are unable to provide informed consent
- Patients who are intubated
Who the study is looking for
- Patients with minimum 3-month history of Congestive Heart Failure admitted to Aurora St. Luke's Medical Center with acute decompensation
- English speaking only
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aurora St. Luke's Medical Center Coordinator of this site? Confirm its status | Milwaukee | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.